Jane Street Group LLC acquired a new stake in shares of iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN – Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 10,150 shares of the company’s stock, valued at approximately $254,000. Jane Street Group LLC owned approximately 6.77% of iShares Neuroscience and Healthcare ETF as of its most recent filing with the Securities & Exchange Commission.
iShares Neuroscience and Healthcare ETF Stock Down 3.3 %
NYSEARCA:IBRN opened at $24.75 on Friday. iShares Neuroscience and Healthcare ETF has a 12 month low of $22.67 and a 12 month high of $28.74. The firm has a market cap of $3.71 million, a price-to-earnings ratio of 28.31 and a beta of 1.06. The company’s 50 day moving average is $26.41 and its 200-day moving average is $25.72.
About iShares Neuroscience and Healthcare ETF
Recommended Stories
- Five stocks we like better than iShares Neuroscience and Healthcare ETF
- What is a Stock Market Index and How Do You Use Them?
- 3 Defense Stocks Gaining From Budget and Interest Rate Pressures
- Do ETFs Pay Dividends? What You Need to Know
- 3 Natural Gas Stocks Set to Thrive in This Winter’s Freeze
- Investing in Commodities: What Are They? How to Invest in Them
- Bullish on Athleisure? Here’s Why Lululemon Stock Shines
Want to see what other hedge funds are holding IBRN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN – Free Report).
Receive News & Ratings for iShares Neuroscience and Healthcare ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Neuroscience and Healthcare ETF and related companies with MarketBeat.com's FREE daily email newsletter.